Arvinas, Inc (ARVN) News

Latest headlines that mention ARVN, newest first · each headline opens the original publisher

ARVN quote

Last price: $7.31
Day change: +0.14%
Next earnings: 2026-11-04

Quote & chart Expected move Insider trading IV rank history

ARVN headlines

latest coverage

Investing.com 25d ago

Arvinas to present ARV-102 Parkinson’s data at MDS congress

General T3ARVN

Seeking Alpha News 1mo ago

Arvinas, Inc. (ARVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

General T2ARVN

Investing.com 1mo ago

Arvinas at Morgan Stanley conference: pipeline focus, capital discipline

General T3ARVN

Yahoo Finance 1mo ago

Arvinas (ARVN) Just Made Protein Degrader History With FDA Nod

General T2ARVN

Investing.com 1mo ago

Arvinas at Wells Fargo conference: pipeline nears key data

General T3ARVN

Seeking Alpha News 1mo ago

Arvinas: Veppanu Approval Underlines Degrader Platform Promise - I'm Bullish

General T2ARVN

Motley Fool 2mo ago

Arvinas (ARVN) Q2 2026 Earnings Call Transcript

VEPPANU's FDA approval and $50 million Pfizer milestone fuel record net income.

Earnings T3ARVN PFE

Investing.com 2mo ago

BTIG reiterates Arvinas stock Buy rating on pipeline execution

General T3ARVN

Seeking Alpha 2mo ago

Arvinas expects cash runway into the second half of 2028 as ARV-102 PSP trials shift to 2027

General T2ARVN

Seeking Alpha News 2mo ago

Arvinas, Inc. (ARVN) Q2 2026 Earnings Call Transcript

Earnings T2ARVN

Seeking Alpha 2mo ago

Arvinas GAAP EPS of $2.58 beats by $2.87, revenue of $249.7M beats by $189.01M

Earnings T2ARVN

Seeking Alpha 2mo ago

Arvinas Q2 2026 Earnings Preview

Earnings T2ARVN

Investing.com 4mo ago

Form 4 Arvinas Inc For: 24 June

General T3ARVN

Seeking Alpha 4mo ago

Rigel to roll out Veppanu in August; Arvinas, Pfizer snag $70M upfront on cleared deal

General T2ARVN PFE

Investing.com 5mo ago

Form 144 Arvinas Inc For: 20 May

General T3ARVN

Yahoo Finance 5mo ago

Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer

General T2ARVN PFE RIGL

Yahoo Finance 5mo ago

These Analysts Increase Their Forecasts On Arvinas After Q1 Results

Earnings T2ARVN

Seeking Alpha 5mo ago

Arvinas anticipates U.S. ARV-102 PSP trial by end of 2026 while maintaining cash runway into second half of 2028

General T2ARVN

Seeking Alpha News 5mo ago

Arvinas, Inc. (ARVN) Q1 2026 Earnings Call Transcript

Earnings T2ARVN

Seeking Alpha News 5mo ago

Arvinas: FDA Approval Validates The Platform, But Does Not Signal Near-Term Profitability

General T2ARVN

Yahoo Finance 5mo ago

Arvinas Q1 Earnings Call Highlights

Earnings T2ARVN

Investing.com 5mo ago

Arvinas stock gains after Rigel deal for VEPPANU rights

General T3ARVN

Seeking Alpha 5mo ago

Pfizer, Arvinas ink licensing deal with Rigel for breast cancer therapy

General T2ARVN PFE

Seeking Alpha 5mo ago

Arvinas GAAP EPS of -$0.90 misses by $0.26, revenue of $15.6M misses by $19.24M

Earnings T2ARVN

Investing.com 5mo ago

Form 10Q Arvinas Inc For: 11 May

General T3ARVN

Seeking Alpha 5mo ago

Arvinas Q1 2026 Earnings Preview

Earnings T2ARVN

Investing.com 5mo ago

Form 144 Arvinas Inc For: 8 May

General T3ARVN

ARVN news alerts

Get an alert by email or push when a new headline mentions ARVN.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.